Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.
- DOI
- 10.3390/antiox14010108
- Published
- 2025 Jan 18
- Container
- Antioxidants (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/antiox14010108,
title = {Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.},
author = {Belenichev I and Popazova O and Bukhtiyarova N and Ryzhenko V and Pavlov S and Suprun E and Oksenych V and Kamyshnyi O},
year = {2025},
journal = {Antioxidants (Basel, Switzerland)},
doi = {10.3390/antiox14010108},
url = {https://doi.org/10.3390/antiox14010108}
}RIS
TY - JOUR TI - Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions. AU - Belenichev I AU - Popazova O AU - Bukhtiyarova N AU - Ryzhenko V AU - Pavlov S AU - Suprun E AU - Oksenych V AU - Kamyshnyi O PY - 2025 JO - Antioxidants (Basel, Switzerland) DO - 10.3390/antiox14010108 UR - https://doi.org/10.3390/antiox14010108 ER -
APA
I, B., O, P., N, B., V, R., S, P., E, S., V, O., & O, K. (2025). Targeting Mitochondrial Dysfunction in Cerebral Ischemia: Advances in Pharmacological Interventions.. Antioxidants (Basel, Switzerland). https://doi.org/10.3390/antiox14010108
Source records
- pubmed · retrieved 2026-09-25T22:19:51.553Z